The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

Anscombe, 1983, Sequential medical trials, Journal of the American Statistical Association, 58, 365, 10.2307/2283272

Armitage, P., 1975. Sequential Medical Trials. Blackwell, Oxford.

Armitage, 1985, The search for optimality in clinical trials, International Statistical Review, 53, 15, 10.2307/1402871

Arrow, 1970, Uncertainty and the evaluation of public investment decisions, American Economic Review, 60, 364

Bather, 1981, Randomised allocation of treatments in sequential experiments, Journal of the Royal Statistical Society B, 43, 265

Bather, 1985, On the allocation of treatment in sequential medical trials, International Statistical Review, 53, 1, 10.2307/1402870

Berry, 1972, A Bernoulli two-armed bandit, Annals of Mathematical Statistics, 43, 871, 10.1214/aoms/1177692553

Berry, 1978, Modified two-armed bandit strategies for certain clinical trials, Journal of the American Statistical Association, 73, 339, 10.2307/2286662

Berry, 1994, Discussion of the paper by Spiegelhalter, Freedman and Parmar, Journal of the Royal Statistical Society A, 157, 399

Claxton, K., 1997. The value of clinical information: an economic approach to research priority setting. D. Phil. Economics. University of York.

Claxton, K., Posnett, J., 1996a. The role of decision analysis in structuring the economic evaluation of sequential clinical decision problems. University of York Discussion Papers in Economics 96/24.

Claxton, 1996, An economic approach to clinical trial design and research priority setting, Health Economics, 5, 513, 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9

Collins, R., Peto, R., Gray R., Parish, S., 1996. Large scale randomised evidence: trials and overviews. In: Weatherall, D., Ledingham, J.G.G., Warrell, D.A. (Eds.), Oxford Textbook of Medicine, Vol. 1. Oxford Univ. Press, Oxford.

Colton, 1963, A model for selecting one of two medical treatments, Journal of the American Statistical Association, 58, 388, 10.2307/2283274

Colton, 1965, A two-stage model for selecting one of two treatments, Biometrics, 21, 169, 10.2307/2528361

Culyer, A.J., 1991. The normative economics of health care finance and provision. In: McGuire, A., Fenn, P., Mayhew, K. (Eds.), Providing Health Care: The Economics of Alternative Systems of Finance and Provision. Oxford Univ. Press, Oxford.

Culyer, 1996, Mark Pauly on welfare economics: normative rabbits from positive hats, Journal of Health Economics, 15, 243, 10.1016/0167-6296(95)00040-2

Deber, 1990, Using explicit decision rules to manage issues of justice, risk and ethics in decision analysis: when is it not rational to maximize expected utility?, Medical Decision Making, 10, 181, 10.1177/0272989X9001000305

Freedman, 1987, Equipoise and the ethics of clinical research, New England Journal of Medicine, 317, 141, 10.1056/NEJM198707163170304

Garber, 1997, Economic foundations of cost-effectiveness analysis, Journal of Health Economics, 16, 1, 10.1016/S0167-6296(96)00506-1

Garber, A.M., Weinstein, M.C., Torrence, G.W., Kamlet, M.S., 1996. Theoretical foundations of cost-effectiveness analysis. In: Gold, M.R., Siegal, J.E., Russell, L.B., Weinstein, M.C. (Eds.), Cost-effectiveness in Health and Medicine. Oxford Univ. Press, New York.

Hey, J.D., 1984. Decisions under uncertainty. In: van der Ploeg, F. (Ed.), Mathematical Methods in Economics. Wiley, Chichester.

Hoel, D.G., Sodel, M., Weiss, G.H., 1975. A survey of adaptive sampling for clinical trials. In: Elashoff, R. (Ed.), Perspectives in Biometry. Academic Press, New York.

Johannesson, 1993, On the decision rules of cost-effectiveness analysis, Journal of Health Economics, 12, 459, 10.1016/0167-6296(93)90005-Y

Johnson, 1991, At what level of collective equipoise does a clinical trial become ethical, Journal of Medical Ethics, 17, 23, 10.1136/jme.17.1.30

Lachin, 1981, Introduction to sample size determination and power analysis for clinical trials, Controlled Clinical Trials, 1, 13

Lilford, 1995, Equipoise and the ethics of randomisation, Journal of the Royal Society of Medicine, 88, 552

Lindley, 1994, Discussion of the paper by Spiegelhalter, Freedman and Parmar, Journal of the Royal Statistical Society A, 157, 393

Loomes, 1982, Regret theory: an alternative theory of rational choice under uncertainty, Economics Journal, 92, 805, 10.2307/2232669

Machina, 1987, Choice under uncertainty: problems solved and unsolved, Economic Perspectives, 1, 121, 10.1257/jep.1.1.121

Manning, R., Claxton, K., 1997. Experimental and econometric solutions to selection bias. Paper Presented at the Health Economists Study Group. University of York.

McCellan, M., Newhouse, J.P., 1997. The marginal cost-effectiveness of medical technology: a panel instrumental-variables approach. Journal of Econometrics, 39–64.

Mullahy, 1996, What you don't know cant hurt you? Statistical issues in designing medical technology evaluation standards, Medical Care, 34, 124

Mullahy, J., 1997. Which cost-effectiveness ratio? Evaluation of health policies and medical technologies in a stochastic context. Unpublished draft.

O'Brien, 1994, Statistical vs. quantitative significance in the socioeconomic evaluation of medicine, Pharmacoeconomics, 5, 389, 10.2165/00019053-199405050-00005

O'Brien, 1994, In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care, Medical Care, 32, 150, 10.1097/00005650-199402000-00006

Pauly, 1994, A re-examination of the meaning and importance of supplier-induced demand, Journal of Health Economics, 13, 369, 10.1016/0167-6296(94)90037-X

Phelps, 1988, Focusing technology assessment using medical decision theory, Medical Decision Making, 8, 279, 10.1177/0272989X8800800409

Phelps, 1991, On the near equivalence of cost-effectiveness and cost-benefit analysis, International Journal of Technology Assessment in Health Care, 7, 12, 10.1017/S0266462300004803

Pocock, 1992, When to stop a clinical trial, British Medical Journal, 305, 235, 10.1136/bmj.305.6847.235

Pratt, 1996, Willingness to pay and the distribution of risk and wealth, Journal of Political Economy, 104, 747, 10.1086/262041

Raiffa, H., 1968. Decision Analysis: Introductory Lectures on Choices Under Uncertainty. Addison-Wesley, New York.

Raiffa, H., Schlaifer, R., 1959. Probability and Statistics for Business Decisions. McGraw-Hill, New York.

Reinhardt, 1992, Reflections on the meaning of efficiency: can efficiency be separated from equity?, Yale Law Policy Review, 10, 302

Schlaifer, R., 1961. Introduction to Statistics for Business Decisions. McGraw-Hill, New York.

Schwartz, 1967, Explanatory and pragmatic attitudes in therapeutical trials, Journal of Chronic Disease, 20, 637, 10.1016/0021-9681(67)90041-0

Schwartz, D., Flamant, R., Lellouch, J., 1980. Clinical Trials. Harcourt Brace Jovanovich, London.

Spiegelhalter, D.J., Freedman, L.S., 1988. Bayesian approaches to clinical trials. Bayesian Statistics, Vol. 3. Oxford Univ. Press, Oxford.

Spiegelhalter, 1994, Bayesian approaches to randomised trials, Journal of the Royal Statistical Society A, 157, 357, 10.2307/2983527

Stinnett, A.A., Mullahy, J., 1998. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making, forthcoming.

Stinnett, 1996, Mathematical programming for the efficient allocation of health care resources, Journal of Health Economics, 15, 641, 10.1016/S0167-6296(96)00493-6

Upton, 1976, The importance of the patient horizon in the sequential analysis of binomial clinical trials, Biometrika, 63, 335, 10.1093/biomet/63.2.335

Wakker, 1995, Confidence intervals for cost/effectiveness ratios, Health Economics, 4, 373, 10.1002/hec.4730040503

Weinstein, 1990, Principles of cost-effective resource allocation in health care organisations, International Journal of Technology Assessment in Health Care, 6, 93, 10.1017/S0266462300008953

Weinstein, M.C., 1995. From cost-effectiveness ratios to resource allocation: where to draw the line? In: Sloan, F.A. (Ed.), Valuing Health Care: Cost, Benefits and Effectiveness of Pharmaceuticals and Other Medical Technologies. Cambridge Univ. Press, Cambridge.

Weinstein, 1972, Critical ratios and efficient allocation, Journal of Public Economics, 2, 716

Whitehead, J., 1992. The Design and Analysis of Sequential Trials. Ellis Horwood, London.

Willan, 1996, Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem, Health Economics, 5, 297, 10.1002/(SICI)1099-1050(199607)5:4<297::AID-HEC216>3.0.CO;2-T

Zelen, 1969, Play the winner rule and the controlled clinical trial, Journal of the American Statistical Association, 64, 131, 10.2307/2283724